C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/02 (2006.01) C12N 5/078 (2010.01) C07K 16/28 (2006.01) G01N 33/566 (2006.01) C07K 14/705 (2006.01)
Patent
CA 2619682
In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein. Also provided is a cell culture system for assaying T cell stimulation.
Corvalan Jose Ramon
Davis C. Geoffrey
Gilman Steven Christopher
Hanke Jeffrey Herbert
Hanson Douglas Charles
Abgenix Inc.
Amgen Fremont Inc.
Pfizer Inc.
Smart & Biggar
LandOfFree
Human monoclonal antibodies to ctla-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monoclonal antibodies to ctla-4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibodies to ctla-4 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1405490